The FDA’s Upper East Regional Office reports that a particular variety of Postinor 2 that has a label featuring a pink blossom on the pack is not registered.
“Postinor 2 is a drug we are all familiar with, and we know it is something we use for preventing pregnancies, but this particular one with the pink flower has not been registered by the FDA,” stated the Authority through Mr. Abel Ndego, Principal Regulatory Officer.
He claimed that because the brand in question had not been through the Authority’s system, the FDA was unable to determine its efficacy or safety.
“We have also undertaken quality product monitoring of this particular product, and we have noticed that the Active Pharmaceutical Ingredient that should instigate the ability of the product to prevent pregnancy is not at the required value.
“And so once you use it, you would not get the needed pharmaceutical implication,” Mr Ndego said when he addressed participants at the Regional launch of the Goodlife Health Fair in Bolgatanga.
The Regional Health Directorate and NORSAAC organized a three-day Fair to promote health and wellness among the public, encouraging behavior change and improved access to essential healthcare services.
The theme was “Promoting good health through uptake of positive health behaviour.” The event emphasized the importance of purchasing pharmaceutical products from accredited licensed pharmacies and over-the-counter outlets, as storage affects medicine efficacy.
The Principal Regulator and FDA officials displayed unregulated pharmaceutical products at the Fair, warning participants about the dangers of these products.
They highlighted the dangers of products claiming to cure various diseases and warned against purchasing products with obscene images on packaging. The event aimed to educate participants on the dangers of purchasing unregulated pharmaceutical products and their potential health consequences.
